Entrada Therapeutics Inc (TRDA) P/E ratio is 12.47
Entrada Therapeutics Inc (TRDA) P/E ratio is 12.47 as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full TRDA research page for quote, filings, and the rest of the model. This satellite exists so “Entrada Therapeutics Inc P/E ratio” can rank with the actual number, then send you to /stock/trda.